CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 23 enrolled
Drug / intervention
Km+ Mfx+ Pto + H + Cfz +E+Zcombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03057756
NCT03057756N/ACompleted
CompareCT.gov

Nine Months' Short Course Regimen Protocol for the Treatment of Multidrug Resistance-tuberculosis (MDR-TB) Patients in Gabon

Centre de Recherche Médicale de Lambaréné·observational·Posted Feb 20, 2017·Updated Mar 17, 2026

In Brief

An observational study evaluating Km+ Mfx+ Pto + H + Cfz +E+Z for Multi-drug Resistant Tuberculosis. Completed, enrolled 23 participants across 1 site.

Detailed Summary

The principal objective is to evaluate a cure rate and number of adverse events of with confirmed multidrug-resistant tuberculosis patient treated with a 9months regimen.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMulti-drug Resistant Tuberculosis
CountriesGabon
CollaboratorsInstitute of Tropical Medicine, University of Tuebingen, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 20, 2017
Enrollment StartSep 11, 2015
Primary CompletionApr 4, 2023
Study CompletionMay 1, 2023
TodayJul 2, 2026
Enrollment to primary: 7.6 yearsPosted 9.4 years ago

Interventions

Km+ Mfx+ Pto + H + Cfz +E+Zcombination

Second generation of anti tuberculosis Kanamycine, Moxifloxacine,Prothionamide, isoniazide,Clofazimine, Ethambutol,Pyrazinamide